BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26670723)

  • 1. The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.
    Khoury H; Lavoie L; Welner S; Folkerts K
    Cardiovasc Ther; 2016 Apr; 34(2):115-24. PubMed ID: 26670723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease.
    Berger A; Simpson A; Bhagnani T; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger JS
    Am J Cardiol; 2019 Jun; 123(12):1893-1899. PubMed ID: 31014542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review.
    Lavoie L; Khoury H; Welner S; Briere JB
    Cardiovasc Ther; 2016 Jun; 34(3):152-60. PubMed ID: 26915344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
    Mehran R; Baber U; Steg PG; Ariti C; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Berger PB; Iakovou I; Dangas G; Waksman R; Antoniucci D; Sartori S; Krucoff MW; Hermiller JB; Shawl F; Gibson CM; Chieffo A; Alu M; Moliterno DJ; Colombo A; Pocock S
    Lancet; 2013 Nov; 382(9906):1714-22. PubMed ID: 24004642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.
    Wan D; Dehghan M; de Souza RJ; Ramasundarahettige C; Eikelboom JW; Bosch J; Maggioni AP; Bhatt DL; Yusuf S; Anand SS
    Eur J Prev Cardiol; 2023 Jun; 30(8):709-718. PubMed ID: 37080912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease.
    Rossini R; Capodanno D; Lettieri C; Musumeci G; Limbruno U; Molfese M; Spatari V; Calabria P; Romano M; Tarantini G; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2013 Jul; 112(2):150-5. PubMed ID: 23602693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
    Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease.
    Berger A; Simpson A; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger J
    Adv Ther; 2020 Jan; 37(1):240-252. PubMed ID: 31705434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.
    Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.
    Bauersachs R; Zeymer U; Brière JB; Marre C; Bowrin K; Huelsebeck M
    Cardiovasc Ther; 2019; 2019():8295054. PubMed ID: 32099582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
    Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE).
    Rastogi A; Sudhayakumar A; Schaper NC; Jude EB
    Diabetes Metab Syndr; 2023 Nov; 17(11):102875. PubMed ID: 37844433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.
    Rossini R; Musumeci G; Capodanno D; Lettieri C; Limbruno U; Tarantini G; Russo N; Calabria P; Romano M; Inashvili A; Sirbu V; Guagliumi G; Valsecchi O; Senni M; Gavazzi A; Angiolillo DJ
    Thromb Haemost; 2015 Feb; 113(2):272-82. PubMed ID: 25274620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very long-term outcome of peripheral arterial disease in patients undergoing percutaneous coronary revascularization: a retrospective analysis.
    Pullara A; D'Ascenzo F; Gonella A; Moretti C; Sciuto F; Omedè PL; Bollati M; Biondi Zoccai G; Gaita F; Sheiban I
    Minerva Cardioangiol; 2012 Dec; 60(6):553-60. PubMed ID: 23147433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry].
    Suárez C; Castillo J; Esmatjes E; Sala J; Cairols M; Montoto C; Barberá G;
    Med Clin (Barc); 2009 Apr; 132(14):537-44. PubMed ID: 19393390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
    Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.